Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04565457 · ClinicalTrials.gov registry record · NA

A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality

A NA study of Prostate Cancer and Head and Neck Cancers, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
43
Enrollment target
2
Study locations

NCT04565457 is a NA study of Prostate Cancer and Head and Neck Cancers that has completed, run by University of Colorado, Denver. The registered enrollment target is 43 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04565457, a NA study of Prostate Cancer and Head and Neck Cancers, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target
2
Study locations

Study Summary

This is Pilot study that investigates the CBCT(Cone beam computed tomography) image quality improvement provided by the 2D antiscatter grid technology. The primary objective is to assess the improvement in tissue visualization in an observer study, which will be conducted in a blinded fashion.

Interventions

  • DEVICE Research CBCT

Study Locations (2)

Colorado

  • University of Colorado Hospital - Aurora

Florida

  • University of Florida Health Proton Therapy Institute - Jacksonville

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2023-04-21
Est. Completion 2025-05-28
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT04565457

The ClinicalTrials.gov registry entry for NCT04565457 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (93% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Research CBCT is the first listed.

NCT04565457 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Florida.

Frequently Asked Questions

What is clinical trial NCT04565457 about?

NCT04565457 is a clinical study titled "A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality". This is Pilot study that investigates the CBCT(Cone beam computed tomography) image quality improvement provided by the 2D antiscatter grid technology. The primary objective is to assess the improvement in tissue visualization in an observer study, which will be conducted in a blinded fashion.

What is the current status of trial NCT04565457?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2023-04-21. Estimated completion is 2025-05-28.

What conditions does trial NCT04565457 study?

This clinical trial studies the following conditions: Prostate Cancer, Head and Neck Cancers, Upper Abdomen Cancers.

What interventions are being tested in trial NCT04565457?

The interventions under investigation include: Research CBCT (DEVICE).

Who is sponsoring clinical trial NCT04565457?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04565457 being conducted?

This trial has 2 study locations across Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.